Login / Signup

Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.

Naoto KatakamiTomoya MitaHidenori YoshiiToshihiko ShiraiwaTetsuyuki YasudaYosuke OkadaYutaka UmayaharaHideaki KanetoTakeshi OsonoiTsunehiko YamamotoNobuichi KuribayashiKazuhisa MaedaHiroki YokoyamaKeisuke KosugiKentaro OhtoshiIsao HayashiSatoru SumitaniMamiko TsugawaMakoto OhashiHideki TakiTadashi NakamuraSatoshi KawashimaYasunori SatoHirotaka WatadaIichiro Shimomuranull null
Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2017)
UMIN000017607.
Keyphrases
  • open label
  • phase iii
  • phase ii
  • clinical trial
  • study protocol
  • cardiovascular disease
  • phase ii study
  • type diabetes
  • wound healing
  • randomized controlled trial
  • double blind
  • squamous cell carcinoma
  • radiation therapy